How Product Launch Teams Can R.A.M.P. Up to Billion Dollar Product Launches in 2022

From mentally preparing team leaders to optimize their performance, to building the right launch team, to crafting the most effective launch strategy, to ensuring that teams execute to bring the drug to market – there are lots of moving parts that must be integrated at the right time.

At ConnectA, over the past 10 years, we have studied (and worked on) many successful 10-figure drug launches to pinpoint exactly what the most profitable launch teams had in common.

And, the thin line that differentiates million-dollar launch sales from billion-dollar drug sales within the first 90 days of launch, often comes down to mastering these four often overlooked launch components.

Resilience. The ability for leadership to navigate challenges, stay focused on the end goal of impacting the lives of patients, and empowered to make sound decisions in even high stress situations or within aggressive deadlines.

Aligned Teams. Choosing the best experts in the field for product launch teams and having a consultant as part of your team helped to create a powerful shared vision that led to an environment of synergy, accountability, and connectedness.

Momentum Planning. Successful launches leveraged tailored solutions designed to engage all stakeholders and reach a larger audience with customized marketing, while meeting compliance requirements.

Persistent Execution. Billion-dollar results were achieved when launch teams remained agile to pivot, empowered to stay committed to executing launch plans, and focused on seeing every action through to get results.

The results that can be achieved by leveraging this R.A.M.P. methodology is not only financially lucrative for the life science company, garnering acclaim as well for launch teams, but it ensures that innovative treatments make it into the hands of those who need it the most: the patients.

Take, for example, the launch of a new dermatologic drug and a cardiovascular product by a Fortune 1000 life sciences company. ConnectA worked closely with the dermatologic drug launch team, implementing the R.A.M.P. structure, while the other product launch team outsourced support to a strategy-only focused consultant.

Two similar drugs, from the same company, with two different launch support – yielded two completely different sales outcomes.

The drug that was launched not following the R.A.M.P. protocol generated $1,020,000,000 millions dollars in sales. However, the drug that was launched with the team that was supported with resilience training, an optimized team structure, with a detailed action plan, and who remained agile through delivery – it generated over $2,840,000,000 dollars.

The difference speaks for itself and can be directly tied back to the four key steps of the R.A.M.P. methodology.

That’s why, since 2012, ConnectA continues to partner with mid-size life science companies to elevate their product launch results by providing tailored support through the entire launch lifecycle, propelling companies to meet or exceed launch goals, while changing the lives of patients around the world.

ConnectA Strategic Solutions Group | A Vetted Team That Gets 10-Figure Results

We are a leading strategic product launch consulting team, partnering with mid-size life science companies to lock in record-breaking launch results. We do this by meeting companies where they are to develop mental resilience among their top performers, expand product launch team synergy, identify innovative and proven launch strategies, and ensure flawless, results-driven execution. Our A-team brings over 180+ years of combined subject matter expertise, helping launch teams seamlessly navigate marketing, commercial, and regulatory areas that often derail product launch success. With our unique R.A.M.P. methodology, our clients have achieved up to 80% higher product launch revenues with 80% fewer delays, enabling them to do what they do best: improve the lives of their patients.